The weekly litigation news digest is live. Subscribe now

IP Verse

Syringe - EP2869813

The patent EP2869813 was granted to Novartis on Nov 21, 2018. The application was filed on Jan 25, 2013 under application number EP13701276A. The patent is currently recorded with a legal status of "Revoked".

EP2869813

NOVARTIS
Application Number
EP13701276A
Filing Date
Jan 25, 2013
Status
Revoked
Jul 29, 2022
Publication Date
Nov 21, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DILGAug 21, 2019KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBADMISSIBLE
HOFFMANN EITLEAug 21, 2019HOFFMANN EITLEADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTDE102008005938
INTERNATIONAL-SEARCH-REPORTUS2006293270
INTERNATIONAL-SEARCH-REPORTUS2011257601
INTERNATIONAL-SEARCH-REPORTWO2007035621
OPPOSITIONEP2869813
OPPOSITIONUS4184593
OPPOSITIONUSD430015S
OPPOSITIONWO2011006877
OPPOSITIONWO2014005728
OPPOSITIONWO9744068
OTHERWO9744068

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents